Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-2-26
|
pubmed:abstractText |
Previous studies have suggested that peptide transport system-1 (PTS-1), the saturable system that transports Tyr-MIF-1, the enkephalins, and related peptides out of the central nervous system (CNS), exhibits stereospecificity. In the present studies, we showed that 125I-L-Tyr-MIF-1, but not 131I-D-Tyr-MIF-1, was cleared from the CNS more rapidly than could be accounted for by nonspecific mechanisms. Such clearance was inhibited by a 1.0 nmol dose of L-Tyr-MIF-1, but not by D-Tyr-MIF-1. Neither L- nor D-Tyr-MIF-1 altered the much lower clearance of I-D-Tyr-MIF-1 from the brain. Radioactivity recovered from the vascular space after the injection of 125I-Tyr-MIF-1 into the lateral ventricle of the brain eluted by HPLC primarily as intact peptide, demonstrating that most of the Tyr-MIF-1 was not degraded during transport. By contrast, the nonsaturable unidirectional influx of Tyr-MIF-1 into the CNS did not distinguish between the isomers. These studies confirm and extend the observations that Tyr-MIF-1 is transported out of the CNS by a saturable, stereospecific transport system as an intact peptide while the influx into the CNS is by a nonsaturable mechanism that does not distinguish between the isomers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/MSH Release-Inhibiting Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Technetium,
http://linkedlifedata.com/resource/pubmed/chemical/tyrosyl-prolyl-leucyl-glycinamide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0361-9230
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
589-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1980229-Animals,
pubmed-meshheading:1980229-Biological Transport, Active,
pubmed-meshheading:1980229-Blood-Brain Barrier,
pubmed-meshheading:1980229-Injections, Intraventricular,
pubmed-meshheading:1980229-Iodine Radioisotopes,
pubmed-meshheading:1980229-MSH Release-Inhibiting Hormone,
pubmed-meshheading:1980229-Male,
pubmed-meshheading:1980229-Mice,
pubmed-meshheading:1980229-Mice, Inbred ICR,
pubmed-meshheading:1980229-Peptides,
pubmed-meshheading:1980229-Rats,
pubmed-meshheading:1980229-Rats, Inbred Strains,
pubmed-meshheading:1980229-Stereoisomerism,
pubmed-meshheading:1980229-Technetium
|
pubmed:year |
1990
|
pubmed:articleTitle |
Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1.
|
pubmed:affiliation |
Veterans Affairs Medical Center, New Orleans, LA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|